Back to
Conjoint Lecturer

Dr Hui-Ming Lin

Medicine & Health
School of Clinical Medicine
  • Book Chapters | 2016
    Lin HM; Rowan D, 2016, 'Metabolomics: An important tool for assessing state of health and risk of disease in nutrigenomics research', in Nutrigenomics and Nutrigenetics in Functional Foods and Personalized Nutrition, pp. 229 - 242
    Book Chapters | 2016
    2016, '- Metabolomics: An Important Tool for Assessing State of Health and Risk of Disease in Nutrigenomics Research', in Nutrigenomics and Nutrigenetics in Functional Foods and Personalized Nutrition, CRC Press, pp. 248 - 261, http://dx.doi.org/10.1201/b15369-15
  • Journal articles | 2023
    2023, 'Characteristics of immune-infiltrating cells in the tumor microenvironment of appendiceal cancer with peritoneal disease.', Journal of Clinical Oncology, 41, pp. 217 - 217, http://dx.doi.org/10.1200/jco.2023.41.4_suppl.217
    Journal articles | 2022
    2022, '1409P Development of a clinically accessible, circulating prognostic lipid biomarker panel in men with mCRPC to guide potential metabolic intervention', Annals of Oncology, 33, pp. S1189 - S1189, http://dx.doi.org/10.1016/j.annonc.2022.07.1895
    Journal articles | 2022
    2022, 'Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer', BMC Medicine, 20, pp. 112, http://dx.doi.org/10.1186/s12916-022-02298-0
    Journal articles | 2022
    2022, 'Harnessing the Heterogeneity of Prostate Cancer for Target Discovery Using Patient-Derived Explants', Cancers, 14, http://dx.doi.org/10.3390/cancers14071708
    Journal articles | 2022
    2022, 'Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin', Cancers, 14, http://dx.doi.org/10.3390/cancers14194792
    Journal articles | 2022
    Strach MC; Yeung N; Apostolov E; Lin H-M; Nagaraju RT; Ansari N; Koh C; Shin J-S; Kench J; Aziz O; Swarbrick A; Horvath LG; Barriuso J; Mahon K, 2022, 'Single-cell transcriptomic analysis of appendiceal cancer peritoneal disease', ANNALS OF ONCOLOGY, vol. 33, pp. S1322 - S1322, http://dx.doi.org/10.1016/j.annonc.2022.07.1791
    Journal articles | 2021
    2021, 'Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer', Prostate Cancer and Prostatic Diseases, 24, pp. 860 - 870, http://dx.doi.org/10.1038/s41391-021-00338-z
    Journal articles | 2021
    2021, 'Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase', EBioMedicine, 72, http://dx.doi.org/10.1016/j.ebiom.2021.103625
    Journal articles | 2021
    2021, 'Relationship between circulating lipids and cytokines in metastatic castration‐resistant prostate cancer', Cancers, 13, pp. 4964 - 4964, http://dx.doi.org/10.3390/cancers13194964
    Journal articles | 2019
    2019, 'Clinical validation of circulating cytokines as markers of prognosis and response to docetaxel in men with metastatic castration resistant prostate cancer', Oncology Abstracts, http://dx.doi.org/10.1530/oncolabs.1.p032
    Journal articles | 2019
    2019, 'Extracellular fatty acids are the major contributor to lipid synthesis in prostate cancer', Molecular Cancer Research, 17, pp. 949 - 962, http://dx.doi.org/10.1158/1541-7786.MCR-18-0347
    Journal articles | 2019
    2019, 'Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial', European Urology, 76, pp. 306 - 312, http://dx.doi.org/10.1016/j.eururo.2018.11.001
    Journal articles | 2018
    Lin HM; Lee BY; Castillo L; Spielman C; Grogan J; Yeung NK; Kench JG; Stricker PD; Haynes AM; Centenera MM; Butler LM; Shreeve SM; Horvath LG; Daly RJ, 2018, 'Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer', Prostate, 78, pp. 308 - 317, http://dx.doi.org/10.1002/pros.23476
    Journal articles | 2018
    Lin HM; Nikolic I; Yang J; Castillo L; Deng N; Chan CL; Yeung NK; Dodson E; Elsworth B; Spielman C; Lee BY; Boyer Z; Simpson KJ; Daly RJ; Horvath LG; Swarbrick A, 2018, 'MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer', Scientific Reports, 8, http://dx.doi.org/10.1038/s41598-018-26050-y
    Journal articles | 2018
    2018, 'MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer', , http://dx.doi.org/10.1101/273284
    Journal articles | 2017
    Lin HM; Mahon KL; Spielman C; Gurney H; Mallesara G; Stockler MR; Bastick P; Briscoe K; Marx G; Swarbrick A; Horvath LG, 2017, 'Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer', British Journal of Cancer, 116, pp. 1002 - 1011, http://dx.doi.org/10.1038/bjc.2017.50
    Journal articles | 2017
    Lin HM; Mahon KL; Weir JM; Mundra PA; Spielman C; Briscoe K; Gurney H; Mallesara G; Marx G; Stockler MR; Prime C; Parton RG; Hoy AJ; Daly RJ; Meikle PJ; Horvath LG, 2017, 'A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer', International Journal of Cancer, 141, pp. 2112 - 2120, http://dx.doi.org/10.1002/ijc.30903
    Journal articles | 2017
    2017, 'Post hoc analysis of a phase III study to test the association between circulating methylated glutathione s transferase (mGSTP1) DNA levels and response to docetaxel (DTX) in metastatic castration resistant prostate cancer (mCRPC).', Journal of Clinical Oncology, 35, pp. 5014 - 5014, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.5014
    Journal articles | 2016
    Bruce HM; Stricker PD; Gupta R; Savdie RR; Haynes AM; Mahon KL; Lin HM; Kench JG; Horvath LG, 2016, 'Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer', Prostate, 76, pp. 1491 - 1500, http://dx.doi.org/10.1002/pros.23233
    Journal articles | 2016
    2016, 'Phase II trial of circulating cytokines as markers of docetaxel (DTX) resistance in metastatic castrate-resistant prostate cancer (mCRPC).', Journal of Clinical Oncology, 34, pp. 5039 - 5039, http://dx.doi.org/10.1200/jco.2016.34.15_suppl.5039
    Journal articles | 2015
    Mahon KL; Lin HM; Castillo L; Lee BY; Lee-Ng M; Chatfield MD; Chiam K; Breit SN; Brown DA; Molloy MP; Marx GM; Pavlakis N; Boyer MJ; Stockler MR; Daly RJ; Henshall SM; Horvath LG, 2015, 'Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer', British Journal of Cancer, 112, pp. 1340 - 1348, http://dx.doi.org/10.1038/bjc.2015.74
    Journal articles | 2014
    2014, 'Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer', British Journal of Cancer, 110, pp. 2462 - 2471, http://dx.doi.org/10.1038/bjc.2014.181
    Journal articles | 2013
    Lee BY; Hochgraefe F; Lin H-M; Castillo L; Wu J; Raftery M; Shreeve SM; Horvath L; Daly R, 2013, 'Focal adhesion kinase: a mediator of docetaxel-resistance in castrate resistant prostate cancer', BJU INTERNATIONAL, 112, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000321969100100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2013
    Lee BY; Hochgräfe F; Lin HM; Castillo L; Wu J; Raftery MJ; Martin Shreeve S; Horvath LG; Daly RJ, 2013, 'Phosphoproteomic profiling identifies focal adhesion kinase as a mediator of docetaxel resistance in castrate-resistant prostate cancer', Molecular Cancer Therapeutics, 13, pp. 190 - 201, http://dx.doi.org/10.1158/1535-7163.MCT-13-0225-T
    Journal articles | 2013
    2013, 'The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC).', Journal of Clinical Oncology, 31, pp. e22175 - e22175, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e22175
    Journal articles | 2011
    Lin HM; Edmunds SJ; Zhu S; Helsby NA; Ferguson LR; Rowan DD, 2011, 'Metabolomic analysis reveals differences in urinary excretion of kiwifruit-derived metabolites in a mouse model of inflammatory bowel disease', Molecular Nutrition and Food Research, 55, pp. 1900 - 1904, http://dx.doi.org/10.1002/mnfr.201100302
    Journal articles | 2011
    Lin HM; Helsby NA; Rowan DD; Ferguson LR, 2011, 'Using metabolomic analysis to understand inflammatory bowel diseases', Inflammatory Bowel Diseases, 17, pp. 1021 - 1029, http://dx.doi.org/10.1002/ibd.21426
    Journal articles | 2011
    Otter D; Cao M; Lin HM; Fraser K; Edmunds S; Lane G; Rowan D, 2011, 'Identification of urinary biomarkers of colon inflammation in IL10 -/- mice using short-column LCMS metabolomics', Journal of Biomedicine and Biotechnology, 2011, http://dx.doi.org/10.1155/2011/974701
    Journal articles | 2010
    Lin HM; Barnett MP G; Roy NC; Joyce NI; Zhu S; Armstrong K; Helsby NA; Ferguson LR; Rowan DD, 2010, 'Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn?s disease', Journal of Proteome Research, 9, pp. 1965 - 1975, http://dx.doi.org/10.1021/pr901130s
    Journal articles | 2009
    Lin HM; Edmunds SJ; Helsby NA; Ferguson LR; Rowan DD, 2009, 'Nontargeted urinary metabolite profiling of a mouse model of crohn's disease', Journal of Proteome Research, 8, pp. 2045 - 2057, http://dx.doi.org/10.1021/pr800999t
    Journal articles | 2007
    Lin HM; Chatterjee A; Lin YH; Anjomshoaa A; Fukuzawa R; McCall JL; Reeve AE, 2007, 'Genome wide expression profiling identifies genes associated with colorectal liver metastasis', Oncology Reports, 17, pp. 1541 - 1549, http://dx.doi.org/10.3892/or.17.6.1541
    Journal articles | 2005
    Lin HM; Gerrard JA; Shaw IC, 2005, 'Stability of the insecticide cypermethrin during tomato processing and implications for endocrine activity', Food Additives and Contaminants, 22, pp. 15 - 22, http://dx.doi.org/10.1080/02652030400027938
    Journal articles | 2005
    Rasiah IA; Sutton KH; Low FL; Lin HM; Gerrard JA, 2005, 'Crosslinking of wheat dough proteins by glucose oxidase and the resulting effects on bread and croissants', Food Chemistry, 89, pp. 325 - 332, http://dx.doi.org/10.1016/j.foodchem.2004.02.052
    Journal articles | 2004
    Low F; Lin HM; Gerrard JA; Cressey PJ; Shaw IC, 2004, 'Ranking the risk of pesticide dietary intake', Pest Management Science, 60, pp. 842 - 848, http://dx.doi.org/10.1002/ps.904
  • Other | 2023
    2023, Data from Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer, , http://dx.doi.org/10.1158/1541-7786.c.6540204.v1
    Other | 2023
    2023, Supplementary Figures 1-3 from Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer, , http://dx.doi.org/10.1158/1541-7786.22512309
    Other | 2023
    2023, Supplementary Figures 1-3 from Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer, , http://dx.doi.org/10.1158/1541-7786.22512309.v1
    Conference Abstracts | 2022
    2022, 'Modulation of the plasma lipidomic profile with simvastatin in metastatic castration-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 40, http://dx.doi.org/10.1200/JCO.2022.40.6_suppl.154
    Conference Abstracts | 2022
    2022, 'Patient-derived explant model of appendiceal cancer.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000863680301323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    2022, 'Patient-derived explant model of appendiceal cancer.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. 4160 - 4160, http://dx.doi.org/10.1200/jco.2022.40.16_suppl.4160
    Conference Abstracts | 2022
    2022, 'Single-cell transcriptomic analysis of appendiceal cancer peritoneal disease', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, Vol. 33, pp. S1322 - S1322, presented at Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 09 September 2022 - 13 September 2022, http://dx.doi.org/10.1016/j.annonc.2022.07.1791
    Conference Abstracts | 2021
    2021, 'Association of ceramide metabolism with resistance to androgen receptor signalling inhibitors in metastatic prostate cancer', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, Vol. 32, pp. S666 - S667, presented at Congress of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 16 September 2021 - 21 September 2021, http://dx.doi.org/10.1016/j.annonc.2021.08.1148
    Conference Abstracts | 2021
    2021, 'Impact of combined lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC)', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, Vol. 32, pp. S642 - S643, presented at Congress of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 16 September 2021 - 21 September 2021, http://dx.doi.org/10.1016/j.annonc.2021.08.1109
    Conference Abstracts | 2020
    2020, 'Lipidomic analysis of circulating lipids across the natural history of prostate cancer identifies aberrant ceramide metabolism', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-4761
    Conference Abstracts | 2019
    2019, 'Clinical validation of circulating cytokines as markers of prognosis and response to docetaxel in men with metastatic castration-resistant prostate cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 37, presented at ASCO-SITC Clinical Immuno-Oncology Symposium, CA, San Francisco, 28 February 2019 - 02 March 2019, http://dx.doi.org/10.1200/JCO.2019.37.7_suppl.230
    Conference Abstracts | 2019
    2019, 'Company Profiles', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 33 - 33, http://dx.doi.org/10.1111/ajco.13198
    Conference Papers | 2017
    2017, 'The plasma lipidome in castration-resistant prostate cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.5055
    Conference Papers | 2013
    Horvath L; Chatfield MD; Lee-Ng M; Lin H-M; Castillo L; Breit SN; Brown DA; Molloy MP; Marx GM; Pavlakis N; Boyer MJ; Stockier MR; Wykes R; Henshall SM; Mahon KL, 2013, 'The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419605294&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Lee BY; Hochgraefe F; Lin HM; Castillo L; Raftery M; Horvath LG; Daly RJ, 2012, 'Overcoming Docetaxel Resistance in Prostate Cancer by Targeting FAK Phosphorylation, and Its Mode of Action', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, IRELAND, European Org Res & Treatment Canc (EORTC), Dublin, pp. 48 - 49, presented at 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, IRELAND, European Org Res & Treatment Canc (EORTC), Dublin, 06 November 2012 - 09 November 2012, http://dx.doi.org/10.1016/S0959-8049(12)71956-1